Physician profile
Mark Daniels
NPI 1831149905
$1,707.44
in general payments reported to CMS, 2019-2025
12 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.28 · 2022: $1,291 · 2023: $88.57 · 2024: $160 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,150.62 | 2022 | |
| Allergan, INC. | $139.89 | 2022 | |
| Abbott Laboratories | $138.43 | 2025 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $62.51 | 2024 | |
| Kestra Medical Technology Services, INC. | $44.20 | 2023 | Assure Wcd |
| Irhythm Technologies, INC. | $33.34 | 2024 | Zio Xt Patch, Zio Monitor |
| Ethicon US, LLC | $31.03 | 2023 | Mega Soft |
| Boston Scientific Corporation | $30.28 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.76 | 2024 | Xarelto |
| Terumo Medical Corporation | $19.12 | 2024 | Metacross Otw, Tr Band |
| Abiomed | $18.92 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $13.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.